The comparative tests results indicated that Leron
Post# of 148168
(Total Views: 450)
Posted On: 01/11/2022 1:58:40 PM
The comparative tests results indicated that Leronlimab performed better...that came from the results posted. The FDA did not say it was a better drug...the findings indicated that. Gild has an inferior drug...that they bought from immunomedic for 21Billion.
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼